Marco Seehawer
-
- Cancer Genomics and Diagnostics 2
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 1
-
- Pancreatic and Hepatic Oncology Research 1
- Peptidase Inhibition and Analysis 1
-
- RNA modifications and cancer 1
- Fibroblast Growth Factor Research 1
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 2
-
- Brain Metastases and Treatment 1
- Co-authors
- Lars ZenderPierluigi RamadoriDominik PfisterMathias HeikenwälderXin LiKornélia PolyákZheqi LiJun Nishida
- Cited by
- Cancer ResearchHepatologyOncology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Nature reviews. Cancer (1 paper)Nature Cell Biology (2 papers)
- Partner nations
- United StatesAustriaGermany
In The Last Decade
Marco Seehawer
8 papers receiving 509 citations
Hit Papers
Peers
Comparison fields: 5 of 74
- Cancer Research 152
- Hepatology 70
- Oncology 144
- Immunology 97
- Molecular Biology 242
Countries citing papers authored by Marco Seehawer
This map shows the geographic impact of Marco Seehawer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Seehawer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Seehawer more than expected).
Fields of papers citing papers by Marco Seehawer
This network shows the impact of papers produced by Marco Seehawer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Seehawer. The network helps show where Marco Seehawer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marco Seehawer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 21 | |
| 3 | 2024 | 13 | |
| 4 | 2024 | 15 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 18 | |
| 7 | 2022 | 51 | |
| 8 | The immunological and metabolic landscape in primary and metastatic liver cancerbreakdown → | 2021 | 392 |
About Marco Seehawer
Marco Seehawer is a scholar working on Cancer Research, Hepatology and Oncology, having authored 8 papers that have together received 512 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Cancer Genomics and Diagnostics (2 papers), Pancreatic and Hepatic Oncology Research (1 paper), RNA modifications and cancer (1 paper), Fibroblast Growth Factor Research (1 paper), Peptidase Inhibition and Analysis (1 paper), Hepatocellular Carcinoma Treatment and Prognosis (1 paper) and Brain Metastases and Treatment (1 paper). The work is most often cited by research in Cancer Research (152 citations), Hepatology (70 citations) and Oncology (144 citations). Marco Seehawer has collaborated with scholars based in United States, Austria and Germany. Frequent co-authors include Lars Zender, Pierluigi Ramadori, Dominik Pfister, Mathias Heikenwälder, Xin Li, Kornélia Polyák, Zheqi Li, Jun Nishida, Pengze Yan and Pierre Foidart. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature reviews. Cancer and Nature Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.